Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Plos One|February 11, 2026
A gene-specific RNA enrichment protocol for nanopore direct-RNA sequencingMaja Bele Dyrendalsli, Cecilie Løkke, Christer Einvik
Cancer Informatics|March 20, 2019
Clinically Relevant Biomarker Discovery in High-Risk Recurrent NeuroblastomaPeter Utnes, Cecilie Løkke, Trond Flægstad, et al.
Oncology Letters|November 9, 2018
Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cellsSwapnil Parashram Bhavsar, Cecilie Løkke, Trond Flægstad, et al.
Cancer Genomics & Proteomics|August 10, 2019
Interferon-γ Sensitises Human Osteosarcoma Cells to Trail-mediated ApoptosisIdun M Mikkelsen, Cecilie Løkke, Trond Flagstad, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 3, 2010
Inhibition of gene function in mammalian cells using short-hairpin RNA (shRNA)Jørn Remi Henriksen, Jochen Buechner, Cecilie Løkke, et al.
Frontiers in Pediatrics|April 10, 2023
Hsa-miR-323a-3p functions as a tumor suppressor and targets STAT3 in neuroblastoma cellsSwapnil Parashram Bhavsar, Lotte Olsen, Cecilie Løkke, et al.
Nucleic Acids Research|April 12, 2007
Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell linesJørn R Henriksen, Cecilie Løkke, Martin Hammerø, et al.
BMC Developmental Biology|January 4, 2011
Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastomaJørn R Henriksen, Bjørn Helge Haug, Jochen Buechner, et al.
Anticancer Research|May 13, 2015
Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAsBjørn Helge Haug, Øyvind H Hald, Peter Utnes, et al.
Oncotarget|May 3, 2018
MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCNSarah Andrea Roth, Øyvind H Hald, Steffen Fuchs, et al.
Pageof 2